Biotech investment leader Steven Burrill will discuss trends in the life sciences industry Nov. 15

INSITE Policy and Practice Seminar — Biotech 2012/2013: Where are we? Where are we going?

INSITE’s next Policy and Practice Seminar will feature distinguished UW-Madison alumnus G. Steven Burrill, founder and CEO of Burrill & Co. He has been involved in the growth and prosperity of the biotechnology industry for over 40 years and currently serves on the Boards of Directors of AliveCor (Chairman), Catalyst Biosciences, Depomed (NASDAQ: DEPO), NewBridge, Novadaq (NASDAQ: NVDQ), Targacept (NASDAQ: TRGT) and XDx. In 2002 he was recognized as a biotech investment visionary by the Scientific American magazine (The Scientific American 50), and he is the Chairman of the Board of the National Science and Technology Medals Foundation. At this event, he will discuss important trends in the life sciences industry.

Talk: “Biotech 2012/2013: Where are we? Where are we going?”
Date: Thursday, November 15, 2012
Place: Wisconsin School of Business, room 1310
Time: 8:00 AM refreshments; 8:30 AM – 9:45 AM talk
Registration: INSITE Seminar Registration